Treatment of COVID-19: implications for antimicrobial resistance in Africa

There is currently no approved pharmaceutical product for the treatment of COVID-19. However, antibiotics are currently being used for the management of COVID-19 patients in many settings either treat to co-infections or for the treatment of COVID-19 itself. In this commentary, we highlight that the...

Descripción completa

Detalles Bibliográficos
Autores principales: Iwu, Chinwe Juliana, Jordan, Portia, Jaja, Ishmael Festus, Iwu, Chidozie Declan, Wiysonge, Charles Shey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The African Field Epidemiology Network 2020
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687464/
https://www.ncbi.nlm.nih.gov/pubmed/33282074
http://dx.doi.org/10.11604/pamj.supp.2020.35.23713
_version_ 1783613524785758208
author Iwu, Chinwe Juliana
Jordan, Portia
Jaja, Ishmael Festus
Iwu, Chidozie Declan
Wiysonge, Charles Shey
author_facet Iwu, Chinwe Juliana
Jordan, Portia
Jaja, Ishmael Festus
Iwu, Chidozie Declan
Wiysonge, Charles Shey
author_sort Iwu, Chinwe Juliana
collection PubMed
description There is currently no approved pharmaceutical product for the treatment of COVID-19. However, antibiotics are currently being used for the management of COVID-19 patients in many settings either treat to co-infections or for the treatment of COVID-19 itself. In this commentary, we highlight that the increased rates of antimicrobial prescribing for COVID-19 patients could further worsen the burden of antimicrobial resistance (AMR). We also highlight that though AMR is a global threat, Africa tends to suffer most from the consequences. We, therefore, call on African countries not to lose sight of the possible implications of the treatment of COVID-19 on AMR and a need to redouble efforts towards the fight against AMR while dealing with the pandemic.
format Online
Article
Text
id pubmed-7687464
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The African Field Epidemiology Network
record_format MEDLINE/PubMed
spelling pubmed-76874642020-12-03 Treatment of COVID-19: implications for antimicrobial resistance in Africa Iwu, Chinwe Juliana Jordan, Portia Jaja, Ishmael Festus Iwu, Chidozie Declan Wiysonge, Charles Shey Pan Afr Med J Commentary There is currently no approved pharmaceutical product for the treatment of COVID-19. However, antibiotics are currently being used for the management of COVID-19 patients in many settings either treat to co-infections or for the treatment of COVID-19 itself. In this commentary, we highlight that the increased rates of antimicrobial prescribing for COVID-19 patients could further worsen the burden of antimicrobial resistance (AMR). We also highlight that though AMR is a global threat, Africa tends to suffer most from the consequences. We, therefore, call on African countries not to lose sight of the possible implications of the treatment of COVID-19 on AMR and a need to redouble efforts towards the fight against AMR while dealing with the pandemic. The African Field Epidemiology Network 2020-07-20 /pmc/articles/PMC7687464/ /pubmed/33282074 http://dx.doi.org/10.11604/pamj.supp.2020.35.23713 Text en ©Chinwe Juliana Iwu et al. https://creativecommons.org/licenses/by/4.0 Pan African Medical Journal (ISSN: 1937-8688). This is an Open Access article distributed under the terms of the Creative Commons Attribution International 4.0 License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Commentary
Iwu, Chinwe Juliana
Jordan, Portia
Jaja, Ishmael Festus
Iwu, Chidozie Declan
Wiysonge, Charles Shey
Treatment of COVID-19: implications for antimicrobial resistance in Africa
title Treatment of COVID-19: implications for antimicrobial resistance in Africa
title_full Treatment of COVID-19: implications for antimicrobial resistance in Africa
title_fullStr Treatment of COVID-19: implications for antimicrobial resistance in Africa
title_full_unstemmed Treatment of COVID-19: implications for antimicrobial resistance in Africa
title_short Treatment of COVID-19: implications for antimicrobial resistance in Africa
title_sort treatment of covid-19: implications for antimicrobial resistance in africa
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687464/
https://www.ncbi.nlm.nih.gov/pubmed/33282074
http://dx.doi.org/10.11604/pamj.supp.2020.35.23713
work_keys_str_mv AT iwuchinwejuliana treatmentofcovid19implicationsforantimicrobialresistanceinafrica
AT jordanportia treatmentofcovid19implicationsforantimicrobialresistanceinafrica
AT jajaishmaelfestus treatmentofcovid19implicationsforantimicrobialresistanceinafrica
AT iwuchidoziedeclan treatmentofcovid19implicationsforantimicrobialresistanceinafrica
AT wiysongecharlesshey treatmentofcovid19implicationsforantimicrobialresistanceinafrica

Ejemplares similares